+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

United Kingdom Metabolic Disorders Market Outlook to 2033 - Diabetes Assays and Cholesterol Tests

  • PDF Icon

    Report

  • 33 Pages
  • June 2025
  • Region: United Kingdom
  • GlobalData
  • ID: 6108284
The “United Kingdom Metabolic Disorders Market Outlook to 2033” is a comprehensive databook report, covering key market data on the United Kingdom Metabolic Disorders market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Diabetes Assays and Cholesterol Tests

The United Kingdom Metabolic Disorders Market report provides key information and data on:

  • Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
  • 2024 company share data for Metabolic Disorders Market.
  • Global corporate-level profiles of key companies operating within the United Kingdom Metabolic Disorders Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

United Kingdom Metabolic Disorders is segmented as follows:

  • Diabetes Assays
  • Cholesterol Tests

Reasons to Buy

The United Kingdom Metabolic Disorders Market report helps you to develop:

  • Business strategies by identifying the key market segments poised for strong growth in the future.
  • Market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • Understand the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Metabolic Disorders Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Metabolic Disorders Market, United Kingdom
3.1 Metabolic Disorders Market, United Kingdom, Revenue ($m), 2018-2033
3.1.1 Cholesterol Tests Market, United Kingdom, Revenue ($m), by Segment, 2018-2033
3.1.2 Diabetes Assays Market, United Kingdom, Revenue ($m), by Segment, 2018-2033
3.2 Metabolic Disorders Market, United Kingdom, Volume (Units), 2018-2033
3.2.1 Cholesterol Tests Market, United Kingdom, Volume (Units), by Segment, 2018-2033
3.2.2 Diabetes Assays Market, United Kingdom, Volume (Units), by Segment, 2018-2033
3.3 Metabolic Disorders Market, United Kingdom, Average Price ($), 2018-2033
3.4 Metabolic Disorders Market, United Kingdom, Company Share by Revenue ($m), 2024
4 Overview of Key Companies in United Kingdom, Metabolic Disorders Market
4.1 Siemens Healthineers AG
4.1.1 Company Overview
4.2 Abbott Laboratories
4.2.1 Company Overview
4.3 Beckman Coulter Inc
4.3.1 Company Overview
4.4 Roche Diagnostics International Ltd
4.4.1 Company Overview
4.5 Ortho Clinical Diagnostics Holdings Plc
4.5.1 Company Overview
4.6 Thermo Fisher Scientific Inc
4.6.1 Company Overview
4.7 Danaher Corp
4.7.1 Company Overview
5 Metabolic Disorders Market Pipeline Products
6 Recent Developments
6.1 Product News
6.1.1 Apr 02, 2025: Sequential Announces Launch of Multi-Omic Studies
7 Appendix
7.1 Research Methodology
7.1.1 Coverage
7.1.2 Secondary Research
7.1.3 Primary Research
7.1.4 Market Modeling and Forecasting
7.1.5 Company Share Analysis
7.1.6 Benchmarking
7.2 the analyst Consulting
7.3 Contact the Publisher
7.4 Disclaimer
List of Tables
Table 1: Metabolic Disorders Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Table 2: Cholesterol Tests Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Table 3: Diabetes Assays Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Table 4: Metabolic Disorders Market, United Kingdom, Volume (Units), 2018-2033
Table 5: Cholesterol Tests Market, United Kingdom, Volume (Units), 2018-2033
Table 6: Diabetes Assays Market, United Kingdom, Volume (Units), 2018-2033
Table 7: Metabolic Disorders Market, United Kingdom, Average Price ($), 2018-2033
Table 8: Metabolic Disorders Market, United Kingdom, Company Share by Revenue ($m), 2024
Table 9: Metabolic Disorders Market Pipeline Products
Table 10: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country
List of Figures
Figure 1: Metabolic Disorders Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Figure 2: Cholesterol Tests Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Figure 3: Diabetes Assays Market, United Kingdom, Revenue ($m), USD Constant, 2018-2033
Figure 4: Metabolic Disorders Market, United Kingdom, Volume (Units), 2018-2033
Figure 5: Cholesterol Tests Market, United Kingdom, Volume (Units), 2018-2033
Figure 6: Diabetes Assays Market, United Kingdom, Volume (Units), 2018-2033
Figure 7: Metabolic Disorders Market, United Kingdom, Company Share (%), 2024

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories